Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/12/15/2574421/0/en/ASLAN-Pharmaceuticals-Announces-First-Patient-Screened-in-Study-of-Eblasakimab-in-Dupilumab-Experienced-Atopic-Dermatitis-Patients.html
Dec 15, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next